AbbVie · 1 day ago
2026 siRNA Conjugate Development Intern (PhD)
North Chicago, IL
Internship
Onsite
Intern
$59K/yr - $100K/yr
Start in 2026 SummerAbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The internship focuses on developing a kinetic model for siRNA conjugation to antibodies, enhancing the understanding of this platform and contributing to potential peer-reviewed publications.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Establishment of a robust lab-scale process that generates stable antibody-siRNA conjugates
Development of a mathematical model based on experimental data to enable precise predictions of how variations in reaction conditions modulate conjugation efficiency and stability
Qualification
Required
Currently enrolled in university, pursuing a PhD in chemical engineering, material science and engineering, pharmaceutical sciences and engineering, or other related field
Must be enrolled in university for at least one semester following the internship
Experience with bioconjugation and/or kinetic modeling
Excellent organizational skills and research and development expertise
Demonstrated strong communication skills with the ability to clearly communicate theories and concepts
Preferred
Expected graduation date between December 2026 – July 2027
Experience with antibody-drug conjugation and conjugation reaction optimization
Analytical methodology such as size exclusion chromatography and hydrophobic interaction chromatography
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
Founded in 2013
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
yicaiglobal.com
2026-01-19
2026-01-18
Company data provided by crunchbase